Anxiety Rx denials: 12.5% overturned by independent reviewers
In 24 California IMR decisions from 2019 to 2026, reviewers overturned the plan 3 times (12.5%). In the last five years: 7.7% of 13. Denials reach IMR only when a member appeals all the way; read the caveats below before generalising.
By diagnosis
| Diagnosis category | Decisions | Overturned | Last 5 years |
|---|---|---|---|
| Mental Disorder | 20 | 10.0% | 0.0% of 10 |
By year (last five)
| Year | Decisions | Overturned |
|---|---|---|
| 2021 | 6 | 16.7% |
| 2022 | 1 | 0.0% |
| 2023 | 2 | 0.0% |
| 2024 | 1 | 0.0% |
| 2025 | 2 | 0.0% |
| 2026 | 1 | 0.0% |
What the findings mention
| What the findings mention | Decisions | Overturned | All decisions here |
|---|---|---|---|
| Published evidence citedThe findings refer to peer-reviewed or published evidence. | 10 | 20.0% | 12.5% |
| Records did not supportThe findings say the documentation did not show what was needed (usually an upheld denial). | 4 | 0.0% | 12.5% |
| Guidelines or criteria citedThe findings cite guidelines, criteria or a standard of care. | 3 | 0.0% | 12.5% |
| Alternatives contraindicatedThe findings mention a contraindication to the plan's preferred option. | 3 | 0.0% | 12.5% |
Keyword matches on the reviewer’s findings, not causes. A tag that appears mostly in overturned decisions is worth documenting in an appeal; it is not a guarantee.
From recent overturned decisions
“Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage Aptiom and Banzel.Banzel and Aptiom are both approved by the U.S. Food and Drug Administration for the management of epilepsy. It is estimated that 20 to 40 percent of seizure patients have drug-resistant epilepsy. Trials of additional anti-seizure medications can be of benefit in individuals with drug-resistant epilepsy. …”
“Nature of Statutory Criteria/ Case Summary: The enrollee is requesting authorization and coverage for a three month refill of Effexor 150mg, a three month refill of Seroquel 200mg, individual psychotherapy every two weeks, and monthly visits with a psychiatrist. The enrollee has chronic recurrent depression and anxiety, exacerbated by recent stressors. Her symptoms were relatively well-managed until she had a …”
“Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for clonazepam 0.5 mg. Medical literature notes that benzodiazepines with an intermediate to long onset of action such as clonazepam might have “less potential for abuse and less risk of rebound” and thus helpful for chronic management of GAD. One study reported that clonazepam can be “successfully discontinued …”
- California only: these are decisions by independent reviewers under California's IMR program (plans regulated by the Department of Managed Health Care). Other states and self-funded employer plans use different reviewers and rules.
- Selection: only denials that a member took all the way to IMR appear. Most denials are never appealed, and the ones that reach an external reviewer are not a random sample.
- Overturned means the reviewer disagreed with the plan; it does not mean the treatment worked or that a similar request will be approved.
- Argument tags are keyword matches on the reviewer's findings. They describe what the findings mention, not why the case was decided.
- Categories are DMHC's own labels (treatment sub-category and diagnosis category); 'Other' is a catch-all and is excluded from rankings.
Source: California Department of Managed Health Care, Independent Medical Review (IMR) Determinations, Trend (CHHS Open Data). Public California government data; Apellica's aggregates and tags are CC BY 4.0.
Questions
How often were Anxiety Rx denials overturned?
In 24 California IMR decisions from 2019 to 2026, reviewers overturned the plan 3 times (12.5%). In the last five years: 7.7% of 13.
What did the reviewers' findings mention in overturned cases?
The table on this page counts keyword matches in the findings: prior therapies tried, contraindications, guidelines cited, published evidence, whether the records supported the request. They describe what the findings say, not why the case was decided.
Does a California IMR result apply to my plan?
Only California plans regulated by the Department of Managed Health Care go to IMR. Other states and self-funded employer plans use different reviewers, but the reasoning is the same kind: criteria, documentation and alternatives. Use the findings as a guide to what to document.
Related: California appeal rights · California external-review reversal rate · The levers library · CSV
Independent reviewers reverse plans when the record answers the criteria. Upload the denial letter; a senior reviewer reads it within 24 hours and tells you in writing whether it can be appealed and how. $0 upfront, 10% of what is recovered, nothing if we do not recover. Not a law firm.